[1]姚光弼.临床肝脏病学[M].上海:上海科学技术出版社, 2004∶449-496.
|
[2] 中华医学会传染病与寄生虫学分会, 肝病学分会, 传染病信息[J].2000, 13 (4) ∶141.
|
[3]赵景民, 王松山, 孙艳玲, 等.自身免疫性肝炎临床病理特征及发病机理的研究[J].中华实验和临床病毒学杂志, 2002, 16 (1) ∶27-30.
|
[4]孟宪镛.实用消化病诊疗学[M].上海:世界图书出版公司, 2001∶435.
|
[5]周永昌, 郭万学.超声医学[M].第三版.北京:科学技术文献出版社, 2002∶785.
|
[1] | Mingming ZHANG, Huan LIU, Dongmei ZHANG, Dongbo WU, Hong TANG. Primary biliary cholangitis-autoimmune hepatitis overlap syndrome comorbid with pulmonary cryptococcosis: A case report[J]. Journal of Clinical Hepatology, 2024, 40(8): 1666-1669. doi: 10.12449/JCH240825 |
[2] | Zhenqi LI, Ning DU, Hongyang He. Association between primary sclerosing cholangitis and the risk of colorectal cancer: A two-sample Mendelian randomization study[J]. Journal of Clinical Hepatology, 2023, 39(3): 567-572. doi: 10.3969/j.issn.1001-5256.2023.03.013 |
[3] | Xin SUN, Tingyu ZHANG, Yuhao YAO, Ziwei GUO, Jiaxin ZHANG, Yongan YE, Xiaoke LI. Highlights of the EASL clinical practice guidelines on sclerosing cholangitis versus the latest Chinese guideline[J]. Journal of Clinical Hepatology, 2023, 39(1): 43-49. doi: 10.3969/j.issn.1001-5256.2023.01.007 |
[4] | Ziyi LI, Wanjie ZHANG, Fuchun WANG, Xiaorong MAO, Junfeng LI. Role of T lymphocytes in primary sclerosing cholangitis[J]. Journal of Clinical Hepatology, 2023, 39(12): 2926-2931. doi: 10.3969/j.issn.1001-5256.2023.12.026 |
[5] | Chinese Society of Hepatology. Guidelines on the diagnosis and management of primary biliary cholangitis (2021)[J]. Journal of Clinical Hepatology, 2022, 38(1): 35-41. doi: 10.3760/cma.j.cn112138-20211112-00794 |
[6] | Haiping ZHANG, Huiping YAN, Dexi CHEN, Yingmin MA. The role of pathogen infections in the development and progression of autoimmune liver diseases[J]. Journal of Clinical Hepatology, 2022, 38(4): 754-758. doi: 10.3969/j.issn.1001-5256.2022.04.004 |
[7] | Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the diagnosis and management of primary sclerosing cholangitis (2021)[J]. Journal of Clinical Hepatology, 2022, 38(1): 50-61. doi: 10.3760/cma.j.cn112138-20211109-00786 |
[8] | Shan HaiXia, Wu AiHua, Hou JinLin, Zhu YouFu. Clinical and pathological characteristics of autoimmune liver disease.[J]. Journal of Clinical Hepatology, 2008, 24(2): 111-113. |
[9] | Gao Feng, Zhang FuKui, Jia JiDong. Liver function changes of ursodeoxycholic acid made in china for patients with primary biliary cirrhosis.[J]. Journal of Clinical Hepatology, 2008, 24(4): 278-280. |
[11] | Tang ShuZhen, Liu XiaoMing, You Hong, Zhang FuKui, Wang BaoEn, Jia JiDong. Autoimmune related clinical tests in diagnosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2006, 22(3): 191-192. |
[12] | Yin MingShi, Po HongXin, Han XueJi, Tai YongRi, Zhou ZhenXia. Increased chymase in livers with autoimmune disease:Co-localization with fibrosis[J]. Journal of Clinical Hepatology, 2005, 21(1): 9-12. |
[16] | Zhang Fang, Ceng XiaoBo, Su XianShi, Li ManNi. Significance of Assaying Serum Prealbumin in the patients with viral Hepatitis B[J]. Journal of Clinical Hepatology, 2001, 17(3): 163-164. |
[17] | He WenTao, Shi JianShi. Clinical analysis of primary bilary cirrhosis.[J]. Journal of Clinical Hepatology, 2001, 17(3): 180-181. |